Flaherty, Keith T <br/><br/>
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Aug 2008 
 - 4836-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-07-4123  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzenesulfonates--administration & dosage<br/>Biopsy<br/>Carboplatin--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Niacinamide--analogs & derivatives<br/>Paclitaxel--administration & dosage<br/>Phenylurea Compounds<br/>Pyridines--administration & dosage<br/>Sorafenib<br/>Time Factors<br/>Treatment Outcome